Molecular imaging 'sees' inside coronary arteries to measure disease

June 11, 2012, Society of Nuclear Medicine

Patients with cardiovascular disease will now benefit from a powerful new molecular imaging tool to detect disease in the main arteries supplying oxygen to the heart, say researchers presenting studies at the Society of Nuclear Medicine's 2012 Annual Meeting.

When an active heart needs more oxygen, blood vessels have a natural ability to open more so that greater amounts of blood can flow. The maximum dilation possible is the coronary flow reserve or CFR. This is an important reference, because it is one of the earliest signs of , which is caused by atherosclerosis, a narrowing or hardening of these arteries due to a build-up of cholesterol and . Diseased coronary arteries are unable to dilate as fully as healthy blood vessels, potentially limiting to the .

The considers cardiovascular disease the number one cause of death and disability across the globe. Coronary artery disease is just one of a range of these diseases that can cause serious problems, including heart attack, if left untreated.

In two studies presented at the meeting, investigators examined quantitative imaging data to determine the true extent of coronary artery disease. In one study, researchers tested a method called myocardial perfusion imaging, also known as a stress test, conducted with positron emission tomography (PET). They then measured the CFR and calculated the precise dilation of blood vessels at rest and under stress. The objective of the study was to compare this technique's ability to predict to a more conventional imaging method called angiography. In the other study, researchers used a PET and measured CFR to determine whether age is always a risk factor for arterial disease.

"The quantification of CFR with molecular imaging provides a substantial advantage for unmasking coronary artery disease, even in patients who would otherwise be considered healthy with normal myocardial perfusion imaging," says Michael Fiechter, M.D., lead investigator of one study in cardiac imaging at the department of radiology for University Hospital Zurich, Zurich, Switzerland.

Measuring CFR goes beyond traditional myocardial perfusion imaging, which is based on visual interpretation of the differences between blood flow at rest and under stress, and instead actually quantifies coronary artery disease using imaging data acquired during scanning. The molecular imaging technique is made possible with PET, which uses injected imaging probes that emit signals picked up by a specialized scanner. Coronary artery disease is often evaluated using angiography, an X-ray procedure that involves catheterization and the injection of a dye into the coronary arteries in order to image blood flow and structure of the vessels, and echocardiography, which uses sound waves to image the heart.

"Although different studies revealed a prognostic value of CFR, this study is the first that systematically assessed the diagnostic value of CFR against invasive coronary angiography as a standard of reference for detection of coronary artery disease," says Philipp Kaufmann, M.D., a lead author of one of the studies in the department of radiology and cardiac imaging at University Hospital Zurich, Zurich, Switzerland.

In the two presented studies, a total of 777 elderly participants underwent myocardial perfusion imaging with PET and either Rb-82 or N-13-ammonia as an imaging biomarker to evaluate quantitative CFR as an indicator for coronary artery disease. One study of 73 participants concluded significant improvements across five different reference points including sensitivity, positive predictive value, and accuracy of myocardial perfusion imaging compared to imaging studies without CFR measurements.

In a separate study of 704 patients over the age of 75, researchers using similar methods discovered that age was not necessarily a risk factor for developing disease, as was once thought.

"This is the first large study of the effects of aging on coronary vascular function in patients," says Venkatesh Murthy, M.D., Ph.D., cardiovascular medicine and imaging fellow at Brigham and Women's Hospital and Harvard Medical School in Boston, Mass. "Aging has been previously shown in small studies to affect vascular performance, but these have generally used less accurate methodologies. We demonstrate that many older adults have preserved coronary vascular function and that this group has an extremely favorable prognosis. They are much less likely to die from cardiac causes compared to those with abnormal coronary vascular function. This work suggests that loss of vascular function may not be an inevitable consequence of aging."

Results of the research revealed that myocardial perfusion imaging with PET and either Rb-82 or N-13-ammonia with added quantitative CFR measurements significantly improved sensitivity and diagnostic value of stress testing over alone. The evidence also shows that this molecular imaging technique is extremely accurate and may provide more information for identifying coronary vascular disease and for exploring why some people develop the disease and others do not.

"The primary message of our study is that aging does not always imply decline in vascular function and that the many people with preserved have far better prognosis— about half the risk of dying from heart disease," says Murthy.

Explore further: The next stage of heart function testing

Related Stories

The next stage of heart function testing

October 11, 2011
A new non-invasive technique for measuring how well the heart and blood vessels function in patients already suffering from coronary artery disease could, in a single test, identify which abnormally narrowed blood vessels ...

Recommended for you

A nanoparticle inhalant for treating heart disease

January 18, 2018
A team of researchers from Italy and Germany has developed a nanoparticle inhalant for treating people suffering from heart disease. In their paper published in the journal Science Translational Medicine, the group describes ...

Starting periods before age of 12 linked to heightened risk of heart disease and stroke

January 15, 2018
Starting periods early—before the age of 12—is linked to a heightened risk of heart disease and stroke in later life, suggests an analysis of data from the UK Biobank study, published online in the journal Heart.

'Decorated' stem cells could offer targeted heart repair

January 10, 2018
Although cardiac stem cell therapy is a promising treatment for heart attack patients, directing the cells to the site of an injury - and getting them to stay there - remains challenging. In a new pilot study using an animal ...

Two simple tests could help to pinpoint cause of stroke

January 10, 2018
Detecting the cause of the deadliest form of stroke could be improved by a simple blood test added alongside a routine brain scan, research suggests.

Exercise is good for the heart, high blood pressure is bad—researchers find out why

January 10, 2018
When the heart is put under stress during exercise, it is considered healthy. Yet stress due to high blood pressure is bad for the heart. Why? And is this always the case? Researchers of the German Centre for Cardiovascular ...

Heart-muscle patches made with human cells improve heart attack recovery

January 10, 2018
Large, human cardiac-muscle patches created in the lab have been tested, for the first time, on large animals in a heart attack model. This clinically relevant approach showed that the patches significantly improved recovery ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.